1. In this cohort of individuals with type 2 diabetes (T2D), use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a slightly increased risk of developing diabetic retinopathy (DR); however, it is also associated with fewer severe vision-threatening complications.
Alex Chan is an Editor at McMaster University, where he is also a second-year Medical Resident. He focuses on themes related to culture and society, with particular interests in prenatal care, oncology, and mental health care, among other medical topics. Alex's work has been featured in various publications, including Lexology, Outsports, and Gothamist.










